NCT00654121View on ClinicalTrials.gov

Prevention of Clinical Onset of Type 1 Diabetes in High Risk First Degree Relatives

PHASE2CompletedINTERVENTIONAL
Enrollment

112

Participants

Timeline

Start Date

February 29, 2000

Primary Completion Date

April 30, 2004

Study Completion Date

November 30, 2007

Conditions
Diabetes, Type I
Interventions
DRUG

Actrapid HM

56 subjects will receive metabolically active insulin by subcutaneous injections for 36 months (twice daily)

Trial Locations (3)

1090

Academisch Ziekenhuis and Diabetes Research Center - Brussels Free University-VUB, Brussels

3000

Department of Endocrinology and Nephrology, UZ Gasthuisberg, Katholieke Universiteit Leuven -KUL, Leuven

Unknown

Universitair Ziekenhuis Antwerpen, Antwerp

Sponsors

Collaborators (1)

Novo Nordisk A/S
All Listed Sponsors
collaborator

Novo Nordisk A/S

INDUSTRY

lead

AZ-VUB

OTHER